Correlation Between GlaxoSmithKline PLC and Shriram Finance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Shriram Finance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Shriram Finance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Shriram Finance Limited, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Shriram Finance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Shriram Finance. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Shriram Finance.

Diversification Opportunities for GlaxoSmithKline PLC and Shriram Finance

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Shriram is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Shriram Finance Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shriram Finance and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Shriram Finance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shriram Finance has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Shriram Finance go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Shriram Finance

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 22.31 times less return on investment than Shriram Finance. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.64 times less risky than Shriram Finance. It trades about 0.01 of its potential returns per unit of risk. Shriram Finance Limited is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  127,072  in Shriram Finance Limited on August 29, 2024 and sell it today you would earn a total of  177,563  from holding Shriram Finance Limited or generate 139.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.38%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Shriram Finance Limited

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Shriram Finance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shriram Finance Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Shriram Finance is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Shriram Finance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Shriram Finance

The main advantage of trading using opposite GlaxoSmithKline PLC and Shriram Finance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Shriram Finance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shriram Finance will offset losses from the drop in Shriram Finance's long position.
The idea behind GlaxoSmithKline PLC ADR and Shriram Finance Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals